Grimes & Company, Inc. Abbott Laboratories Transaction History
Grimes & Company, Inc.
- $3.66 Billion
- Q3 2024
A detailed history of Grimes & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Grimes & Company, Inc. holds 57,945 shares of ABT stock, worth $6.87 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
57,945
Previous 56,757
2.09%
Holding current value
$6.87 Million
Previous $5.9 Million
12.02%
% of portfolio
0.18%
Previous 0.18%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,167Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.82 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.52 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.79 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...